New pill could stop debilitating HAE attacks in their tracks
NCT ID NCT02303626
First seen Nov 17, 2025 · Last updated May 24, 2026 · Updated 21 times
Summary
This study tested an oral medication called BCX4161 to prevent sudden swelling attacks in people with hereditary angioedema (HAE), a rare genetic condition. About 110 adults with HAE type I or II took either a low dose, high dose, or placebo daily for 12 weeks. Researchers tracked how many attacks occurred and how many days were attack-free to see if the drug works better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Birmingham, Alabama, 35209, United States
-
Study site
Scottsdale, Arizona, 85251, United States
-
Study site
Granada Hills, California, 91344, United States
-
Study site
San Diego, California, 92093, United States
-
Study site
San Diego, California, 92112, United States
-
Study site
Walnut Creek, California, 94598, United States
-
Study site
Colorado Springs, Colorado, 80907, United States
-
Study site
Shreveport, Louisiana, 71106, United States
-
Study site
Chevy Chase, Maryland, 20815, United States
-
Study site
Boston, Massachusetts, 02114, United States
-
Study site
Plymouth, Minnesota, 55446, United States
-
Study site
St Louis, Missouri, 63141, United States
-
Study site
New York, New York, 10029, United States
-
Study site
Charlotte, North Carolina, 28277, United States
-
Study site
Cincinnati, Ohio, 45267, United States
-
Study site
Oklahoma City, Oklahoma, 73131, United States
-
Study site
Tulsa, Oklahoma, 74133, United States
-
Study site
Lake Oswego, Oregon, 97035, United States
-
Study site
Hershey, Pennsylvania, 17033, United States
-
Study site
Pittsburgh, Pennsylvania, 15241, United States
-
Study site
Dallas, Texas, 75231, United States
-
Study site
Galveston, Texas, 77555, United States
-
Study site
Fairfax, Virginia, 63141, United States
-
Study site
Spokane, Washington, 99204, United States
-
Study site
Tacoma, Washington, 98405, United States
-
Study site
Leuven, Belgium
-
Study site
Ottawa, Canada
-
Study site
Grenoble, France
-
Study site
Lille, France
-
Study site
Paris, France
-
Study site
Berlin, Germany
-
Study site
Frankfurt, Germany
-
Study site
Mörfelden-Walldorf, Germany
-
Study site
Budapest, Hungary
-
Study site
Milan, Italy
-
Study site
Birmingham, United Kingdom
-
Study site
Bristol, United Kingdom
-
Study site
Cardiff, United Kingdom
-
Study site
London, United Kingdom
-
Study site
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.